Screening for colorectal cancer just got radically easier. New Day Diagnostics has launched ColoHealth™, a first-of-its-kind blood test available direct-to-consumer—no bowel prep, no anesthesia, no day off work. It’s already turning heads with one powerful stat: over 99% of people who previously avoided traditional screening went through with this test.
With a sensitivity of 73.3% and a negative predictive value of 99.8%, ColoHealth™ doesn’t just offer convenience—it delivers clinical credibility. It detects nearly twice as many precancers as earlier blood-based options, offering a critical window for early intervention.